Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 27 April 2024
Accepted: 3 June 2024
First Online: 1 July 2024
Conflict of interest
: W. Füreder has received honoraria from Alexion, Apellis, BioCryst, Novartis, Roche and Sobi. R. Thalhammer declares that she has no competing interests. P. Valent has received honoraria from Alexion, Amgen and Novartis.